PC-Domain Enzyme Targeted for Drug Development (G646249)

Target Name: PCED1CP

NCBI ID: G646249

PCED1CP

Other Name(s): PC-esterase domain containing 1C, pseudogene

PC-Domain Enzyme Targeted for Drug Development

The protein encoded by the gene PCED1CP (PC-esterase domain containing 1C, pseudogene) is a member of the superfamily of enzymes known as PCETEs (proteins that contain a PC-domain). These enzymes are involved in a wide range of cellular processes, including metabolism, signal transduction, and cell adhesion. Despite their importance, little is known about PCED1CP and its function in the cell.

The PC-domain is a conserved region that is found in a variety of proteins, including enzymes, toxins, and receptors. The PC-domain is involved in the formation of a covalent complex with other molecules, often through the formation of a disulfide bond . This type of bond is formed by the oxidation of one molecule to the other, resulting in the formation of a new covalent bond.

One of the functions of the PC-domain is the formation of disulfide bonds, which are important for the stability and activity of many proteins. These bonds can be formed by the oxidation of one molecule to the other, resulting in the formation of a new covalent bond. This type of bond is formed by the oxidation of one molecule to the other, resulting in the formation of a new covalent bond.

Another function of the PC-domain is the regulation of protein stability. Many proteins that contain a PC-domain are involved in cell signaling pathways, and the stability of these proteins is important for the proper functioning of these pathways. The PC-domain can be involved in the formation of a covalent bond, which can help to regulate the stability of the protein.

The PC-domain has also been implicated in the regulation of cellular processes such as cell adhesion, migration and invasion.

Targeting PCED1CP as a drug target

The PC-domain is a highly conserved region that is found in many proteins, including enzymes, toxins, and receptors. This makes it an attractive target for drug development. The PC-domain is involved in the formation of disulfide bonds, which are important for the stability and activity of many proteins. These bonds can be formed by the oxidation of one molecule to the other, resulting in the formation of a new covalent bond. resulting in the formation of a new covalent bond.

Targeting PCED1CP as a drug target has the potential to lead to the development of new treatments for a variety of diseases. For example, the PC-domain has been shown to be involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs. Therefore, compounds that can inhibit the activity of the PC-domain have the potential to be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition, the PC-domain is also involved in the regulation of protein stability, which is important for the proper functioning of many proteins. Therefore, compounds that can regulate the activity of the PC-domain have the potential to be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Furthermore, the PC-domain has also been implicated in the regulation of cellular processes such as cell migration and invasion, which are important for the development and progression of many diseases. Therefore, compounds that can inhibit the activity of the PC-domain have the potential to be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Overall, the PC-domain is a highly conserved region that is involved in a wide range of cellular processes. Targeting PCED1CP as

Protein Name: PC-esterase Domain Containing 1C, Pseudogene

The "PCED1CP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCED1CP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets